Effects of i.c.v. losartan on the angiotensin II-mediated vasopressin release and hypothalamic fos expression in near-term ovine fetuses

Peptides

Volumn 27, Issue 9, 2006, Pages 2230-2238

  Shi, Lijun ^a,b,c   Mao, Caiping ^a,c   Wu, Jiawei ^a,c   Morrissey, Paul ^b   Lee, Juanxiu ^a,c   Xu, Zhice ^a,b,c  

^a BEIJING SPORT UNIVERSITY   (China)

^b HARBOR UCLA MEDICAL CENTER   (United States)

^c MEDICAL COLLEGE OF SOOCHOW UNIVERSITY   (China)

Author keywords

AT1 receptor; Fetal vasopressin; Hypothalamic nuclei; Losartan

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; ANGIOTENSIN II; ARGIPRESSIN; LOSARTAN; PROTEIN C FOS; RECEPTOR SUBTYPE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN; CONTROLLED STUDY; DRUG MEGADOSE; FEMALE; FETUS; GESTATIONAL AGE; HORMONE RELEASE; HYPOTHALAMUS; IMMUNOREACTIVITY; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SUPRAOPTIC NUCLEUS; THALAMUS MIDLINE NUCLEUS; VASOPRESSIN BLOOD LEVEL;

ANGIOTENSIN II; ANIMALS; ARGININE VASOPRESSIN; FEMALE; FETUS; HYPOTHALAMUS; IMIDAZOLES; INJECTIONS, INTRAVENTRICULAR; LOSARTAN; PREGNANCY; PROTO-ONCOGENE PROTEINS C-FOS; PYRIDINES; SHEEP; TIME FACTORS; VASOPRESSINS;

OVIS;

EID: 33746902781     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2006.03.013     Document Type: Article

References (35)

1. Bargmann W., and Scharrer E. The site of the hormones of the posterior pituitary. Am Sci 39 (1951) 255-259
2. 2 receptor antagonist, CGP 42112B. Exp Physiol 77 (1992) 761-766
3. Bodineau L., and Larnicol N. Brainstem and hypothalamic areas activated by tissue hypoxia: fos-like immunoreactivity induced by carbon monoxide inhalation in the rat. Neuroscience 108 (2001) 643-653
4. Carey R.M., Wang Z.Q., and Siragy H.M. Role of the angiotensin type 2 receptor in the regulation of blood pressure and renal function. Hypertension 35 (2000) 155-163
5. 2 angiotensin receptor subtype predominates in the 18 day gestation fetal rat brain. Brain Res 560 (1991) 334-336
6. Cushing B.S., and Kramer K.M. Mechanisms underlying epigenetic effects of early social experience: the role of neuropeptides and steroids. Neurosci Biobehav Rev 29 (2005) 1089-1105
7. 2 receptor: fact, fancy and fantasy. Regul Pept 81 (1999) 11-24
8. Engelmann M., Wotjak C.T., Neumann I., Ludwig M., and Landgraf R. Behavioral consequences of intracerebral vasopressin and oxytocin: focus on learning and memory. Neurosci Biobehav Rev 20 (1996) 341-358
9. Ervin M.G., Amico J.A., Leake R.D., Ross M.G., Robinson A.G., and Fisher D.A. Arginine vasotocin and a novel oxytocin-vasotocin-like material in plasma of human newborns. Biol Neonate 53 (1988) 17-22
10. Fitzsimons J.T. Angiotensin, thirst, and sodium appetite. Physiol Rev 78 (1998) 583-686
11. Fregly M.J., and Rowland N.E. Effect of a nonpeptide angiotensin II receptor antagonist, DuP 753, on angiotensin-related water intake in rat. Brain Res Bull 27 (1991) 97-102
12. Gallinat S., Busche S., Raizada M.K., and Sumners C. The angiotensin II type 2 receptor; an enigma with multiple variations. Am J Physiol Endocrinol Metab 278 (2000) E357-E374
13. 2 receptor in the brain of ovine fetus. Dev. Brain Res 150 (2004) 51-61
14. Kullama L.K., Ross M.G., Lam R., Leake R.D., Ervin M.G., and Fisher D.A. Ovine maternal and renal vasopressin receptor response to maternal dehydration. Am J Obstet Gynecol 167 (1992) 1717-1722
15. Leng G., Dyball R.E., and Luckman S.M. Mechanisms of vasopressin secretion. Horm Res 37 (1992) 33-38
16. 2) receptor mRNAs in the adult rat brain: a functional neuroanatomical review. Front Neuroendocrinol 18 (1997) 383-439
17. Mckinley M.J., Allen A.M., Mathai M.L., May C., McAllen R.M., Oldfield B.J., et al. Brain angiotensin and body fluid homeostasis. Jpn J Physiol 51 (2001) 281-289
18. McKinley M.J., McBurnie M.I., and Mathai M.L. Neural mechanisms subserving central angiotensinergic influences on plasma renin in sheep. Hypertension 37 (2001) 1375-1381
19. Qadri F., Culman J., Veltmar A., Maas K., Rascher W., and Unger T.H. Angiotensin II-induced vasopressin release is mediated through alpha-1 adrenoceptors and angiotensin II AT1 receptors in the supraoptic nucleus. J Pharmacol Exp Ther 267 (1993) 567-574
20. Reid I. Actions of angiotensin II on the brain: mechanisms and physiologic role. Am J Physiol 264 (1984) 533-543
21. Robillard J.E., Matson J.R., Sessions C., and Smith F.G. Development aspects of renal tubular reabsorption of water in the lamb fetus. Pediatr Res 13 (1979) 1172-1176
22. Sagar S.M., Sharp F.R., and Curran T. Expression of c-fos protein in brain: metabolic mapping at the cellular level. Science 240 (1998) 1328-1331
23. Shi L., Mao C., Simon T., Sun W., Wu J., Yao J., et al. Effects of i.c.v. losartan on the angiotensin II-mediated pressor responses and c-fos expression in near-term ovine fetus. J Comp Neurol 493 (2005) 571-579
24. Siragy H.M., De Gasparo M., and Carey R.M. Angiotensin type 2 receptor mediates valsartan-induced hypotension in conscious rats. Hypertension 35 (2000) 1074-1077
25. Stevenson K.M., Gibson K.J., and Lumbers E.R. Effects of losartan on the cardiovascular system, renal haemodynamics and function and lung liquid flow in fetal sheep. Clin Exp Pharmacol Physiol 23 (1996) 125-130
26. Thorn N.A. Antidiuretic hormones synthesis, release, and action under normal and pathological circumstances. Adv Metab Disord 4 (1970) 39-73
27. Thrasher T.N., and Keil L.C. Regulation of drinking and vasopressin secretion: role of organum vasculosum laminae terminalis. Am J Physiol 253 (1987) R108-R120
28. Thrasher T.N., and Keil L.C. Systolic pressure predicts plasma vasopressin responses to hemorrhage and vena caval constriction in dogs. Am J Physiol 279 (2000) R1035-R1042
29. Unger T. The angiotensin type 2 receptor: variations on an enigmatic theme. J Hypertens 17 (1999) 1775-1786
30. Weisinger R.S., Blair-West J.R., Burns P., Denton D.A., and Tarjan E. Role of brain angiotensin in thirst and sodium appetite of rats. Peptides 18 (1997) 977-984
31. Wong P.C., Price W.A., Chiu A.T., Duncia J.V., Carini D.J., Wexler R.R., et al. Nonpeptide angiotensin II receptor antagonists. VIII. Charaterization of functional antagonism displayed by DUP 753, an orally active antihypertensive agent. J Pharmacol Exp Ther 252 (1990) 719-725
32. Wright J.W., and Harding J.W. Regulatory role of brain angiotensin in the control of physiological and behavioral responses. Brain Res Rev 17 (1992) 227-262
33. Xu Z., Hu F., Shi L., Morrissey P., Stewart L., and Yao J. Central angiotensin-mediated vasopressin release and activation of hypothalamic neurons in younger fetus at pre-term. Peptides 26 (2005) 307-314
34. Xu Z., Nijland M.J.M., and Ross M.G. Plasma osmolality dipsogenic thresholds and c-fos expression in the near-term ovine fetus. Pediatr Res 49 (2001) 678-685
35. Xu Z., Shi L., Hu F., White R., Stewart L., and Yao J. In utero development of central ANG-stimulated pressor response and hypothalamic fos expression. Dev Brain Res 145 (2003) 169-176